P5‐106: Japanese, multicenter, phase II trial of combination therapy with favipiravir and methylprednisolone for COVID‐19 patients with non‐critical respiratory failure: the J‐critical trial
2021 ◽
Vol 26
(S3)
◽
pp. 200-200
2015 ◽
Vol 27
(5)
◽
pp. 705-716
◽
C. H. Choi
◽
J. G. Kwon
◽
S. K. Kim
◽
S.-J. Myung
◽
K. S. Park
◽
...
2010 ◽
Vol 34
(9)
◽
pp. 1151-1157
◽
Nobu Akiyama
◽
Keisuke Miyazawa
◽
Yoshinobu Kanda
◽
Kaoru Tohyama
◽
Mitsuhiro Omine
◽
...
Nicolas Mounier
◽
Thomas Cluzeau
2013 ◽
Vol 31
(5)
◽
pp. 1294-1299
◽
Yousuke Nakai
◽
Hiroyuki Isayama
◽
Hideaki Ijichi
◽
Takashi Sasaki
◽
Naminatsu Takahara
◽
...
2010 ◽
Vol 8
(3)
◽
pp. 201
D. Yamamoto
◽
T. Taguchi
◽
N. Masuda
◽
T. Nakayama
◽
T. Nagata
◽
...
2009 ◽
Vol 39
(11)
◽
pp. 720-726
◽
N. Shinohara
◽
A. Kumagai
◽
K. Kanagawa
◽
S. Maruyama
◽
T. Abe
◽
...
2013 ◽
Vol 144
(5)
◽
pp. S-547
Chang Hwan Choi
◽
Joong Goo Kwon
◽
Sung-Kook Kim
◽
Seung-Jae Myung
◽
Kyung Sik Park
◽
...
2013 ◽
Vol 54
(7)
◽
pp. 1373-1379
◽
Francine M. Foss
◽
Nelida Sjak-Shie
◽
Andre Goy
◽
Eric Jacobsen
◽
Ranjana Advani
◽
...
M Moehler
◽
J Hartmann
◽
F Lordick
◽
S Al-Batran
◽
P Reimer
◽
...
F Hilpert
◽
C Kurzeder
◽
B Schmalfeldt
◽
P Neuser
◽
N de Gregorio
◽
...
Close
Export Citation Format
Close
Share Document
Close